Deep Breaths: Updates from CHEST

Eosinophilic granulomatosis with polyangiitis and hypereosinophilic syndromes are often mistaken for each other. How can we better distinguish these diseases? Dr. Jared Silver discusses how to diagnose these diseases with Dr. Praveen Akuthota, a pulmonologist from U.C. San Diego Medical Center in California.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Physicians are challenged in adopting the latest clinical guidelines and integrating new and existing treatment advances into practice when managing patients with VTE.

Although evidence corroborates the safety and efficacy of managing low-risk patients with VTE in outpatient settings through prophylactic extension, the majority of this subtype is still being treated in hospital settings.

High risk patients and those with identifiable symptoms are not routinely receiving prophylaxis treatment that could prevent the development of VTE.

Evaluating the need for therapy escalation can be challenging. So joining Dr. Charles Turck to help us understand how to escalate treatment for patients with chronic obstructive pulmonary disease is Dr. Hassan Bencheqroun, Assistant Professor of Medicine at the University of California Riverside School of Medicine.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

To better understand whether or not corticosteroids should be incorporated in treatment for our patients with COPD, Dr. Charles Turck is joined by Dr. Deborah Jo Levine, a Professor of Medicine and Director of the Pulmonary Hypertension Center at the University of Texas Health.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Dr. Charles Turck is joined by Dr. Chitra Lal, a Professor of Medicine at the Medical University of South Carolina in Charleston, to share strategies for adherence to treatment and discuss multiple versus single inhaler triple therapy for COPD.

This is a non-promotional, non-CME disease state disease education podcast series brought to you by American College of CHEST Physicians in collaboration with and paid for by GSK.

Despite widespread eligibility, only half of Americans received their flu vaccine last year, and only 55% have been fully vaccinated against COVID-19. Dr. Randy Young joins host Dr. Michael Greenberg to discuss the latest coadministration guidelines and how they could impact vaccination rates.

This episode is produced in partnership with the American College of CHEST Physicians and sponsored by Sanofi Pasteur.

At least 50 percent of our patients with asthma continue to experience uncontrolled asthma, and they remain at risk of asthma exacerbations, which can be serious. To learn more about the impacts of uncontrolled asthma, Dr. Fernando J. Martinez sits down with Dr. Navitha Ramesh, who discusses how we can better diagnose, assess, and treat this condition.

A non-promotional, non-CME educational program brought to you by CHEST in collaboration with GlaxoSmithKline